MetaCap

IRIDEX Corporation (IRIX)

NASDAQ: IRIXHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD

0.4449-0.0214 (-4.59%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

IRIX stock chart

Technical analysis

Key statistics

All statistics
EPS (TTM)
-$0.19
52-week range
0.4296 – 1.65
Day range
0.4296 – 0.478
Volume / Avg
48.74K / 385.76K
Beta
—

52-week range

$0.4296$1.65

IRIX stock today

IRIDEX (IRIX) closed at $0.4449 on Nov 20, down 4.59% (-$0.0214), versus the S&P 500's 3.70% decline. Trading was light, with 48.74K shares changing hands, about 13% of the average daily volume. At this level, IRIX sits near the bottom of its 52-week range of $0.4296 to $1.65: 73.0% below the high, set on Jan 22, 2026 and 3.6% above the low.

IRIX is down 61.0% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 52.2%. IRIDEX has posted a net loss over the last twelve months (EPS of -$0.19), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About IRIDEX

Company profile

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders.

Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
CEO
Mr. Patrick Mercer
Headquarters
Mountain View, CA
Employees
93
IPO year
1996
Website
iridex.com

Financial highlights

Full financials

In fiscal 2026, IRIDEX generated $52.7 million in revenue, up 8.2% from fiscal 2024. IRIDEX reported a net loss of $4.4 million, compared with a loss of $8.9 million a year earlier. Gross margin was 36.5% (down from 40.1%) and operating margin -4.9%.

IRIDEX annual revenue, net income and EPS
Fiscal yearFY 2026FY 2024FY 2023FY 2022FY 2021
Revenue$52.67M$48.67M$51.87M$56.97M$53.90M
Growth+8.23%-6.17%-8.96%+5.69%+48.30%
Net income$-4.44M$-8.91M$-9.57M$-7.55M$-5.22M
EPS (diluted)$-0.26$-0.54$-0.59$-0.47$-0.34

Analyst forecast

Forecast

Consensus (1 analysts)

none

Avg. price target

$2.75+518.12%

  • Strong buy 0
  • Buy 1
  • Hold 0
  • Sell 0
  • Strong sell 0

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 17, 2026
EPS actual vs est.
$-0.09 vs $-0.04
Surprise
-125.00%

IRIX news

All IRIX news

IRIDEX peers

Health Care sector
IRIX peer companies
CompanyPrice% ChgMarket capCompare
NDRAENDRA Life Sciences Inc.3.58-3.38%$5.36Mvs IRIX
ITOCiTonic Holdings Ltd Class A1.59+6.00%$11.63Mvs IRIX
NUWENuwellis Inc.3.41-10.50%$1.84Mvs IRIX
NXLNexalin Technology Inc.1.38-2.13%$1.71Mvs IRIX
VBIOValion Bio Inc.0.4806-10.98%$1.04Mvs IRIX
QTIQT Imaging Holdings Inc.1.92+2.67%$28.21Mvs IRIX
ECORelectroCore Inc.4.42-8.87%$40.78Mvs IRIX
POCIPrecision Optics Corporation Inc.4.12+1.41%$45.30Mvs IRIX

Indexes, lists and sector

IRIDEX stock FAQ

What is IRIDEX's stock price today?

IRIX last traded at $0.4449 as of Nov 20, 4:00 PM EST, down 4.59% on the day. Prices are delayed at least 15 minutes.

Who is IRIDEX's CEO?

Mr. Patrick Mercer is the chief executive officer of IRIDEX Corporation, which has about 93 employees.

What is the IRIX 52-week high?

The 52-week high for IRIX is $1.65 and the 52-week low is $0.4296. The stock is currently 73.0% below its high.

Compare IRIX